TechForce Robotics and Oncotelic’s PDAOAI engine are automating the critical elements of electronic Batch Records inside the SAPU Bio cGMP facility — cutting cost, lifting compliance, and retiring paper.
OTCQB: NGTF
OTCQB: OTLC
TechForce Robotics and Oncotelic Therapeutics are collaborating to advance autonomous robotics and AI technologies for pharmaceutical manufacturing and clean room operations. Together, the joint development initiative is focused on supporting intelligent workflows within GMP-regulated environments.
The following robotic platforms were showcased during BIO International Convention 2026 as part of the ongoing collaboration between TechForce Robotics and Oncotelic Therapeutics.
LIM-E™ supports internal supply transport and autonomous routing inside the laboratory. Designed to move approved laboratory supplies and properly contained materials between designated facility areas, LIM-E™ helps keep materials moving while laboratory teams stay focused on scientific and operational work.
Kebb-AI™ supports clean room operators through a robotic tablet interface with audio and voice-driven workflow capture. Built for gowned staff who may not be able to easily type or write while gloved, Kebb-i™ helps capture workflow inputs and support operator communication within controlled environments.
PUR-E™ supports clean room operations through mechanical handling and process automation within GMP-regulated environments. Designed to assist with approved handling workflows and repetitive operational steps, PUR-E™ helps reduce manual touchpoints and support consistency in critical laboratory processes.
The TechForce Robotics and Oncotelic Therapeutics teams are collaborating to develop autonomous robotics and AI technologies for pharmaceutical manufacturing, clean room operations, and laboratory automation.
Current areas of collaboration include:
Connect with the teams behind the joint development initiative to learn how autonomous robotics and AI are being applied within regulated pharmaceutical environments.
The TechForce robots aren’t a concept demo — they’re working today inside the SAPU Bio cGMP facility, Oncotelic’s clean-room manufacturing site. SAPU Bio is the heart of the operation: a paperless GMP environment built around electronic Batch Records (EBRs), where every step is digitally captured and every workflow is a candidate for intelligent automation.
LIM-E™ is currently deployed at SAPU Bio for materials transport. PUR-E™ joins the floor this week for clean-room operations automation, including mechanical handling and process steps inside the GMP environment. Kebb-i™, a robotic tablet that interfaces with gowned operators via audio, completes the trio in the clean room, capturing voice-driven workflow input from staff who can’t type or write while gloved. Integrating AI with the EBR workflow is the longer-term play, with robots and software co-evolving inside the same regulated environment.
PDAOAI™ is Oncotelic’s Knowledge Discovery platform, powered by Structural Intelligence. It folds 28 million papers into structure and identifies the root driver, not proximity. It runs in two modes: Knowledge Discovery for drug discovery, and PDAOAI Robotics with PUR-E and LIM-E for AI-powered GMP manufacturing. Same engine. Two corpora.
Learn MoreExplore how Oncotelic Therapeutics and TechForce Robotics are applying a common
AI platform across drug discovery and GMP manufacturing.
Complete the form to access the platform cost breakdown.
Stay up to date on our latest announcements.
Planning a new facility, upgrading laboratory workflows, or evaluating automation initiatives?
Connect with the TechForce Robotics and Oncotelic Therapeutics teams to learn more about the joint development initiative.
TechForce Robotics is an AI-enhanced robotics and automation company focused on the design, deployment, and support of autonomous robotic solutions across a wide range of industries. Through its proprietary robotics technologies and real-world operating environments, TechForce develops intelligent automation platforms that help organizations improve operational efficiency, from hospitality and logistics to highly regulated pharmaceutical manufacturing environments. TechForce Robotics is a wholly owned subsidiary of Nightfood Holdings Inc. (OTCQB: NGTF).
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company applying its proprietary PDAOAI engine to drug discovery and lab automation. PDAOAI is the AI engine that, paired with TechForce’s robotics, is bringing intelligent automation to GMP biomanufacturing. Oncotelic advances novel therapeutics for cancer and immune disorders while commercializing its AI capabilities through partnerships like TechForce.
